SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare receives EIR for Ahmedabad facility

10 Feb 2020 Evaluate

Cadila Healthcare’s topical manufacturing facility located at Ahmedabad, India has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) signifying the successful closure of the audit. The topical manufacturing facility had completed the USFDA audit from December 16, 2019 to December 20, 2019 with zero 483 observations.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

930.95 19.10 (2.09%)
06-May-2026 13:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1846.50
Dr. Reddys Lab 1305.30
Cipla 1363.20
Zydus Lifesciences 930.95
Lupin 2425.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×